Logo image of BGS

B&G FOODS INC (BGS) Stock Fundamental Analysis

NYSE:BGS - US05508R1068 - Common Stock

4.53 USD
+0.14 (+3.19%)
Last: 8/27/2025, 6:40:00 PM
4.4516 USD
-0.08 (-1.73%)
After Hours: 8/27/2025, 6:40:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to BGS. BGS was compared to 90 industry peers in the Food Products industry. Both the profitability and financial health of BGS have multiple concerns. BGS has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

BGS had positive earnings in the past year.
In the past year BGS had a positive cash flow from operations.
In multiple years BGS reported negative net income over the last 5 years.
BGS had a positive operating cash flow in each of the past 5 years.
BGS Yearly Net Income VS EBIT VS OCF VS FCFBGS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

1.2 Ratios

BGS has a worse Return On Assets (-7.62%) than 73.33% of its industry peers.
With a Return On Equity value of -44.65%, BGS is not doing good in the industry: 75.56% of the companies in the same industry are doing better.
The Return On Invested Capital of BGS (5.46%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for BGS is significantly below the industry average of 27.81%.
Industry RankSector Rank
ROA -7.62%
ROE -44.65%
ROIC 5.46%
ROA(3y)-3.53%
ROA(5y)-1.07%
ROE(3y)-19.04%
ROE(5y)-6.78%
ROIC(3y)5.46%
ROIC(5y)5.48%
BGS Yearly ROA, ROE, ROICBGS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

Looking at the Operating Margin, with a value of 9.93%, BGS is in the better half of the industry, outperforming 73.33% of the companies in the same industry.
In the last couple of years the Operating Margin of BGS has declined.
BGS's Gross Margin of 21.37% is in line compared to the rest of the industry. BGS outperforms 50.00% of its industry peers.
In the last couple of years the Gross Margin of BGS has remained more or less at the same level.
Industry RankSector Rank
OM 9.93%
PM (TTM) N/A
GM 21.37%
OM growth 3Y1.19%
OM growth 5Y-2.1%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.91%
GM growth 5Y-1.1%
BGS Yearly Profit, Operating, Gross MarginsBGS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

2

2. Health

2.1 Basic Checks

BGS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for BGS has been increased compared to 1 year ago.
BGS has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, BGS has a worse debt to assets ratio.
BGS Yearly Shares OutstandingBGS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
BGS Yearly Total Debt VS Total AssetsBGS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 1.37, we must say that BGS is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of BGS (1.37) is worse than 65.56% of its industry peers.
The Debt to FCF ratio of BGS is 15.92, which is on the high side as it means it would take BGS, 15.92 years of fcf income to pay off all of its debts.
BGS has a Debt to FCF ratio of 15.92. This is comparable to the rest of the industry: BGS outperforms 56.67% of its industry peers.
A Debt/Equity ratio of 3.96 is on the high side and indicates that BGS has dependencies on debt financing.
BGS's Debt to Equity ratio of 3.96 is on the low side compared to the rest of the industry. BGS is outperformed by 90.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.96
Debt/FCF 15.92
Altman-Z 1.37
ROIC/WACC0.77
WACC7.09%
BGS Yearly LT Debt VS Equity VS FCFBGS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

BGS has a Current Ratio of 2.93. This indicates that BGS is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.93, BGS belongs to the top of the industry, outperforming 81.11% of the companies in the same industry.
A Quick Ratio of 0.89 indicates that BGS may have some problems paying its short term obligations.
BGS has a Quick ratio of 0.89. This is comparable to the rest of the industry: BGS outperforms 51.11% of its industry peers.
Industry RankSector Rank
Current Ratio 2.93
Quick Ratio 0.89
BGS Yearly Current Assets VS Current LiabilitesBGS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2

3. Growth

3.1 Past

The earnings per share for BGS have decreased strongly by -37.35% in the last year.
BGS shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -15.66% yearly.
Looking at the last year, BGS shows a decrease in Revenue. The Revenue has decreased by -6.91% in the last year.
The Revenue has been growing slightly by 3.08% on average over the past years.
EPS 1Y (TTM)-37.35%
EPS 3Y-27.93%
EPS 5Y-15.66%
EPS Q2Q%-50%
Revenue 1Y (TTM)-6.91%
Revenue growth 3Y-2.05%
Revenue growth 5Y3.08%
Sales Q2Q%-4.54%

3.2 Future

The Earnings Per Share is expected to grow by 1.86% on average over the next years.
The Revenue is expected to decrease by -1.92% on average over the next years.
EPS Next Y-27.28%
EPS Next 2Y-12.75%
EPS Next 3Y1.86%
EPS Next 5YN/A
Revenue Next Year-5.14%
Revenue Next 2Y-3.16%
Revenue Next 3Y-1.92%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BGS Yearly Revenue VS EstimatesBGS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
BGS Yearly EPS VS EstimatesBGS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 8.71, the valuation of BGS can be described as reasonable.
Based on the Price/Earnings ratio, BGS is valued cheaply inside the industry as 86.67% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.14, BGS is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 8.50, the valuation of BGS can be described as reasonable.
BGS's Price/Forward Earnings ratio is rather cheap when compared to the industry. BGS is cheaper than 95.56% of the companies in the same industry.
BGS is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.80, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 8.71
Fwd PE 8.5
BGS Price Earnings VS Forward Price EarningsBGS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BGS is valued a bit cheaper than 68.89% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, BGS is valued cheaply inside the industry as 96.67% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 2.9
EV/EBITDA 8.4
BGS Per share dataBGS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-12.75%
EPS Next 3Y1.86%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 17.00%, BGS is a good candidate for dividend investing.
BGS's Dividend Yield is rather good when compared to the industry average which is at 4.61. BGS pays more dividend than 98.89% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, BGS pays a better dividend.
Industry RankSector Rank
Dividend Yield 17%

5.2 History

The dividend of BGS decreases each year by -16.37%.
BGS has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of BGS decreased recently.
Dividend Growth(5Y)-16.37%
Div Incr Years0
Div Non Decr Years1
BGS Yearly Dividends per shareBGS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

The earnings of BGS are negative and hence is the payout ratio. BGS will probably not be able to sustain this dividend level.
DP-26.91%
EPS Next 2Y-12.75%
EPS Next 3Y1.86%
BGS Yearly Income VS Free CF VS DividendBGS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

B&G FOODS INC

NYSE:BGS (8/27/2025, 6:40:00 PM)

After market: 4.4516 -0.08 (-1.73%)

4.53

+0.14 (+3.19%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners76.94%
Inst Owner Change5%
Ins Owners3.76%
Ins Owner Change17.47%
Market Cap362.40M
Analysts47.69
Price Target4.59 (1.32%)
Short Float %18.04%
Short Ratio4.95
Dividend
Industry RankSector Rank
Dividend Yield 17%
Yearly Dividend0.76
Dividend Growth(5Y)-16.37%
DP-26.91%
Div Incr Years0
Div Non Decr Years1
Ex-Date09-30 2025-09-30 (0.19)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-53.51%
Min EPS beat(2)-74.14%
Max EPS beat(2)-32.87%
EPS beat(4)1
Avg EPS beat(4)-35.28%
Min EPS beat(4)-74.14%
Max EPS beat(4)0.96%
EPS beat(8)3
Avg EPS beat(8)-19.64%
EPS beat(12)6
Avg EPS beat(12)-1.04%
EPS beat(16)6
Avg EPS beat(16)-6.9%
Revenue beat(2)0
Avg Revenue beat(2)-5.07%
Min Revenue beat(2)-8.34%
Max Revenue beat(2)-1.81%
Revenue beat(4)0
Avg Revenue beat(4)-3.5%
Min Revenue beat(4)-8.34%
Max Revenue beat(4)-0.33%
Revenue beat(8)2
Avg Revenue beat(8)-2.06%
Revenue beat(12)3
Avg Revenue beat(12)-1.4%
Revenue beat(16)5
Avg Revenue beat(16)-0.98%
PT rev (1m)-16.92%
PT rev (3m)-38.24%
EPS NQ rev (1m)-15.06%
EPS NQ rev (3m)-5.14%
EPS NY rev (1m)-11.24%
EPS NY rev (3m)-9.97%
Revenue NQ rev (1m)-3.91%
Revenue NQ rev (3m)-4.36%
Revenue NY rev (1m)-1.81%
Revenue NY rev (3m)-1.86%
Valuation
Industry RankSector Rank
PE 8.71
Fwd PE 8.5
P/S 0.19
P/FCF 2.9
P/OCF 2.33
P/B 0.72
P/tB N/A
EV/EBITDA 8.4
EPS(TTM)0.52
EY11.48%
EPS(NY)0.53
Fwd EY11.76%
FCF(TTM)1.56
FCFY34.5%
OCF(TTM)1.94
OCFY42.9%
SpS23.28
BVpS6.27
TBVpS-16.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.62%
ROE -44.65%
ROCE 6.91%
ROIC 5.46%
ROICexc 5.57%
ROICexgc 18.19%
OM 9.93%
PM (TTM) N/A
GM 21.37%
FCFM 6.71%
ROA(3y)-3.53%
ROA(5y)-1.07%
ROE(3y)-19.04%
ROE(5y)-6.78%
ROIC(3y)5.46%
ROIC(5y)5.48%
ROICexc(3y)5.54%
ROICexc(5y)5.56%
ROICexgc(3y)18%
ROICexgc(5y)19.45%
ROCE(3y)6.91%
ROCE(5y)6.94%
ROICexcg growth 3Y2.98%
ROICexcg growth 5Y-1.12%
ROICexc growth 3Y8.5%
ROICexc growth 5Y3.01%
OM growth 3Y1.19%
OM growth 5Y-2.1%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.91%
GM growth 5Y-1.1%
F-Score4
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 3.96
Debt/FCF 15.92
Debt/EBITDA 7.28
Cap/Depr 34.79%
Cap/Sales 1.63%
Interest Coverage 1.28
Cash Conversion 57.06%
Profit Quality N/A
Current Ratio 2.93
Quick Ratio 0.89
Altman-Z 1.37
F-Score4
WACC7.09%
ROIC/WACC0.77
Cap/Depr(3y)29.41%
Cap/Depr(5y)36.55%
Cap/Sales(3y)1.24%
Cap/Sales(5y)1.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-37.35%
EPS 3Y-27.93%
EPS 5Y-15.66%
EPS Q2Q%-50%
EPS Next Y-27.28%
EPS Next 2Y-12.75%
EPS Next 3Y1.86%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.91%
Revenue growth 3Y-2.05%
Revenue growth 5Y3.08%
Sales Q2Q%-4.54%
Revenue Next Year-5.14%
Revenue Next 2Y-3.16%
Revenue Next 3Y-1.92%
Revenue Next 5YN/A
EBIT growth 1Y-45.37%
EBIT growth 3Y-0.88%
EBIT growth 5Y0.92%
EBIT Next Year23.68%
EBIT Next 3Y9.52%
EBIT Next 5YN/A
FCF growth 1Y28.12%
FCF growth 3Y27.08%
FCF growth 5Y90.64%
OCF growth 1Y32.55%
OCF growth 3Y11.71%
OCF growth 5Y23%